Zobrazeno 1 - 10
of 104
pro vyhledávání: '"A. Kisserli"'
Autor:
Kisserli, Aymric, Schneider, Nathalie, Audonnet, Sandra, Tabary, Thierry, Goury, Antoine, Cousson, Joel, Mahmoudi, Rachid, Bani-Sadr, Firouze, Kanagaratnam, Lukshe, Jolly, Damien, Cohen, Jacques HM
Publikováno v:
In Immunobiology May 2021 226(3)
Autor:
Brekke, Ole-Lars, Christiansen, Dorte, Kisserli, Aymric, Fure, Hilde, Dahl, Jim Andre, Donvito, Béatrice, Reveil, Brigitte, Ludviksen, Judith Krey, Tabary, Thierry, Mollnes, Tom Eirik, Cohen, Jacques H.M.
Publikováno v:
In Molecular Immunology October 2019 114:139-148
Autor:
Haidar, F. *, Kisserli, A., Tabary, T., McGregor, B., Noel, L.H., Réveil, B., Toupance, O., Rieu, P., Thervet, E., Legendre, C., Morelon, E., Issa, N., Cohen, J.H.M.
Publikováno v:
In American Journal of Transplantation June 2012 12(6):1564-1575
Autor:
Sukhanova, Alyona, Even-Desrumeaux, Klervi, Kisserli, Aymric, Tabary, Thierry, Reveil, Brigitte, Millot, Jean-Marc, Chames, Patrick, Baty, Daniel, Artemyev, Mikhail, Oleinikov, Vladimir, Pluot, Michel, Cohen, Jacques H.M., Nabiev, Igor
Publikováno v:
In Nanomedicine: Nanotechnology, Biology, and Medicine May 2012 8(4):516-525
Publikováno v:
In Computers & Security 2011 30(8):679-691
Autor:
Waitumbi, John N., Donvito, Béatrice, Kisserli, Aymric, Cohen, Jacques H. M., Stoute, José A.
Publikováno v:
The Journal of Infectious Diseases, 2004 Sep . 190(6), 1183-1191.
Externí odkaz:
https://www.jstor.org/stable/30078049
Autor:
Thierry Tabary, Sandra Audonnet, Jacques H. M. Cohen, Lukshe Kanagaratnam, Firouzé Bani-Sadr, Rachid Mahmoudi, Joël Cousson, Damien Jolly, Nathalie Schneider, Aymric Kisserli, Antoine Goury
Publikováno v:
Immunobiology
Immunobiology, Elsevier, 2021, 226 (3), pp.152093. ⟨10.1016/j.imbio.2021.152093⟩
Immunobiology, 2021, 226 (3), pp.152093. ⟨10.1016/j.imbio.2021.152093⟩
Immunobiology, Elsevier, 2021, 226 (3), pp.152093. ⟨10.1016/j.imbio.2021.152093⟩
Immunobiology, 2021, 226 (3), pp.152093. ⟨10.1016/j.imbio.2021.152093⟩
In order to study the mechanisms of COVID-19 damage following the complement activation phase occurring during the innate immune response to SARS-CoV-2, CR1 (the regulating complement activation factor, CD35, the C3b/C4b receptor), C4d deposits on Er
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18804c6bb85d5082b7961b88d7dcbad0
https://hal.univ-reims.fr/hal-03330724
https://hal.univ-reims.fr/hal-03330724
Autor:
Mahmoudi, Rachid, Kisserli, Aymric, Novella, Jean-Luc, Donvito, Béatrice, Dramé, Moustapha, Réveil, Brigitte, Duret, Valérie, Jolly, Damien, Pham, Bach-Nga, Cohen, Jacques H.
Publikováno v:
In Neurobiology of Aging April 2015 36(4):1766-1766
Autor:
Thierry Tabary, Rachid Mahmoudi, Joël Cousson, Jacques H. M. Cohen, Aymric Kisserli, Antoine Goury, Firouzé Bani-Sadr, Sandra Audonnet, Damien Jolly, Lukshe Kanagaratnam, Nathalie Schneider
In order to study the mechanisms of COVID-19 damage following the complement activation phase occurring during the innate immune response to SARS-CoV-2, the CR1, receptor regulating complement activation factor, CR1 (CD35, the C3b/C4b receptor), C4d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8a277be08e7f5ce013862a883bc9b9f
Autor:
Valérie Duret, Rachid Mahmoudi, Jacques H. M. Cohen, Thierry Tabary, Sandra Audonnet, Aymric Kisserli
Publikováno v:
Journal of visualized experiments : JoVE
Journal of visualized experiments : JoVE, JoVE, 2020, ⟨10.3791/60810⟩
Journal of visualized experiments : JoVE, JoVE, 2020, ⟨10.3791/60810⟩
CR1 (CD35, Complement Receptor type 1 for C3b/C4b) is a high molecular weight membrane glycoprotein of about 200 kDa that controls complement activation, transports immune complexes, and participates in humoral and cellular immune responses. CR1 is p